Compounded Sermorelin

A clinician reviews the proposed medical rationale, health history, medications, contraindications, relevant records or labs, alternatives, and state-specific availability. Peptide12 does not guarantee approval or an outcome.

Patients should not follow a public dosing or cycling template. If a clinician determines treatment is medically appropriate, the prescription and monitoring plan are individualized and may change or stop based on response, safety findings, or updated clinical information.

Do not combine sermorelin with peptides, hormones, or supplements without prescriber review. Peptide12 does not use stacking to support bodybuilding, muscle building, physique enhancement, athletic performance, or sports recovery.

Peptide12 does not market sermorelin as a sleep treatment or prescribe it for workout recovery, sports recovery, bodybuilding, muscle building, strength gain, or athletic performance. Sleep or fatigue symptoms should be evaluated for their underlying cause.

Long-term safety cannot be assumed for an individual patient. A clinician should review the proposed indication, evidence limits, contraindications, adverse effects, relevant monitoring, and whether continued treatment remains medically appropriate.

HGH or somatropin supplies recombinant growth hormone, while sermorelin is a GHRH analog that acts at the pituitary. They have different regulatory and clinical contexts, and neither should be prescribed by Peptide12 for bodybuilding, aesthetic enhancement, or athletic performance.

Yes. Baseline labs (IGF-1, fasting glucose, HbA1c, TSH, free T4) are reviewed by your prescribing provider before a prescription is issued. If you have recent labs (within 12 months), you can upload them; otherwise we coordinate at-home or in-network draws. IGF-1 is then rechecked at 8–12 weeks to confirm physiologic response and guide dose adjustments.

Peptide12 partners with state-licensed compounding pharmacies that hold state and federal licensure and undergo regular USP <797> sterility audits. Every batch is third-party tested for identity, potency, sterility, and endotoxin before release. Compounded sermorelin is not FDA-approved as a finished drug product but is prepared from FDA-regulated active ingredients under individualized prescription.

Compounded medications are typically not covered by commercial insurance. Many patients use HSA or FSA funds. Your care team can help you check eligibility and walk you through reimbursement documentation if needed.